Susquehanna International Group’s Rhythm Pharmaceuticals RYTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.88M Sell
77,262
-5,718
-7% -$361K ﹤0.01% 1325
2025
Q1
$4.4M Buy
82,980
+32,316
+64% +$1.71M ﹤0.01% 1347
2024
Q4
$2.84M Buy
50,664
+29,183
+136% +$1.63M ﹤0.01% 1580
2024
Q3
$1.13M Sell
21,481
-2,644
-11% -$139K ﹤0.01% 2522
2024
Q2
$991K Sell
24,125
-79,128
-77% -$3.25M ﹤0.01% 2591
2024
Q1
$4.47M Buy
103,253
+71,021
+220% +$3.08M ﹤0.01% 1099
2023
Q4
$1.48M Buy
32,232
+1,776
+6% +$81.6K ﹤0.01% 2313
2023
Q3
$698K Buy
30,456
+14,158
+87% +$325K ﹤0.01% 2985
2023
Q2
$269K Sell
16,298
-768,257
-98% -$12.7M ﹤0.01% 4344
2023
Q1
$14M Buy
784,555
+90,513
+13% +$1.61M ﹤0.01% 591
2022
Q4
$20.2M Buy
694,042
+479,520
+224% +$14M 0.01% 344
2022
Q3
$5.26M Buy
214,522
+150,261
+234% +$3.68M ﹤0.01% 816
2022
Q2
$267K Buy
64,261
+46,590
+264% +$194K ﹤0.01% 4148
2022
Q1
$204K Sell
17,671
-46,797
-73% -$540K ﹤0.01% 4799
2021
Q4
$643K Buy
64,468
+11,265
+21% +$112K ﹤0.01% 3445
2021
Q3
$695K Buy
53,203
+9,668
+22% +$126K ﹤0.01% 3261
2021
Q2
$852K Sell
43,535
-80,202
-65% -$1.57M ﹤0.01% 3191
2021
Q1
$2.63M Buy
123,737
+72,222
+140% +$1.54M ﹤0.01% 1812
2020
Q4
$1.53M Sell
51,515
-17,751
-26% -$528K ﹤0.01% 2031
2020
Q3
$1.5M Buy
69,266
+59,391
+601% +$1.29M ﹤0.01% 1719
2020
Q2
$220K Sell
9,875
-5,830
-37% -$130K ﹤0.01% 3631
2020
Q1
$239K Buy
+15,705
New +$239K ﹤0.01% 3642
2019
Q4
Sell
-11,782
Closed -$254K 4683
2019
Q3
$254K Sell
11,782
-3,148
-21% -$67.9K ﹤0.01% 3614
2019
Q2
$328K Buy
+14,930
New +$328K ﹤0.01% 3372